Search research articles
Contact Us
Filters
Showing results (141-150 of 250) with videos related to
Page
of 25
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
May 20, 2021
Design, synthesis, and antibacterial evaluation of vancomycin-LPS binding peptide conjugates
Weiwei Shi, Feifei Chen, Xiangman Zou, et al.
Journal of Neural Engineering
|
February 4, 2021
Improving the performance of multisubject motor imagery-based BCIs using twin cascaded softmax CNNs
Jing Luo, Weiwei Shi, Na Lu, et al.
Cancer Science
|
February 15, 2021
PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma
Weibo Chen, Junyi Wu, Weiwei Shi, et al.
The Science of the Total Environment
|
July 12, 2024
Evaluating impacts of climate and management on reservoir water quality using environmental fluid dynamics code
Qingqing Sun, Zhifeng Yan, Jingfu Wang, et al.
International Urology and Nephrology
|
June 19, 2023
The association of normal-range serum phosphorus with immunoglobulin A nephropathy progression: a retrospective cohort study
Xin An, Lin Ding, Yanjiang Yang, et al.
Biomaterials Research
|
February 1, 2022
Combinatorial nanococktails via self-assembling lipid prodrugs for synergistically overcoming drug resistance and effective cancer therapy
Tongyu Li, Weiwei Shi, Jie Yao, et al.
Frontiers in Oncology
|
July 17, 2020
Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma
Weiwei Shi, Shan Zhang, Ding Ma, et al.
Japanese Journal of Clinical Oncology
|
June 14, 2020
Characteristics of genomic alterations in Chinese cholangiocarcinoma patients
Guoping Jiang, Wu Zhang, Ting Wang, et al.
Thoracic Cancer
|
August 27, 2024
Immune-inflammatory markers and clinical characteristics as predictors of the depth of response and prognosis of patients with PD-L1 ≥50% metastatic non-small cell lung cancer receiving first-line immunotherapy
Xixi Zheng, Lili Zhou, Hui Shi, et al.
Cancer Medicine
|
August 11, 2023
UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma
Junyi Wu, Xiangjie Xu, Shasha Wu, et al.
Page
of 25
Search research articles
Search
Showing results (141-150 of 250) with videos related to
Sort By:
Page
of 25
Bioorganic & Medicinal Chemistry Letters
|
May 20, 2021
Design, synthesis, and antibacterial evaluation of vancomycin-LPS binding peptide conjugates
Weiwei Shi, Feifei Chen, Xiangman Zou, et al.
Journal of Neural Engineering
|
February 4, 2021
Improving the performance of multisubject motor imagery-based BCIs using twin cascaded softmax CNNs
Jing Luo, Weiwei Shi, Na Lu, et al.
Cancer Science
|
February 15, 2021
PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma
Weibo Chen, Junyi Wu, Weiwei Shi, et al.
The Science of the Total Environment
|
July 12, 2024
Evaluating impacts of climate and management on reservoir water quality using environmental fluid dynamics code
Qingqing Sun, Zhifeng Yan, Jingfu Wang, et al.
International Urology and Nephrology
|
June 19, 2023
The association of normal-range serum phosphorus with immunoglobulin A nephropathy progression: a retrospective cohort study
Xin An, Lin Ding, Yanjiang Yang, et al.
Biomaterials Research
|
February 1, 2022
Combinatorial nanococktails via self-assembling lipid prodrugs for synergistically overcoming drug resistance and effective cancer therapy
Tongyu Li, Weiwei Shi, Jie Yao, et al.
Frontiers in Oncology
|
July 17, 2020
Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma
Weiwei Shi, Shan Zhang, Ding Ma, et al.
Japanese Journal of Clinical Oncology
|
June 14, 2020
Characteristics of genomic alterations in Chinese cholangiocarcinoma patients
Guoping Jiang, Wu Zhang, Ting Wang, et al.
Thoracic Cancer
|
August 27, 2024
Immune-inflammatory markers and clinical characteristics as predictors of the depth of response and prognosis of patients with PD-L1 ≥50% metastatic non-small cell lung cancer receiving first-line immunotherapy
Xixi Zheng, Lili Zhou, Hui Shi, et al.
Cancer Medicine
|
August 11, 2023
UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma
Junyi Wu, Xiangjie Xu, Shasha Wu, et al.
Page
of 25